Shopping Cart 0
Cart Subtotal
AED 0

Mitsubishi Tanabe Pharma Corp (4508) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

Mitsubishi Tanabe Pharma Corp (4508)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, diabetes, kidney diseases, central nervous system (CNS) disorders and others. It also develops vaccines for preventing various infectious diseases. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe and North America. Mitsubishi Tanabe is headquartered in Chuo-ku, Osaka, Japan.

Mitsubishi Tanabe Pharma Corp Key Recent Developments

Apr 26,2019: BioInvent receives EUR0.75 million milestone under Mitsubishi Tanabe Pharma partnership

Mar 28,2019: The global health innovative technology fund provides grant for joint research into anti-malarial drugs conducted by Mitsubishi Tanabe Pharma and a malaria research institution

Mar 20,2019: Mitsubishi Tanabe Pharma: Aiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative officeAiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative office

Oct 09,2018: Astellas, Mitsubishi Tanabe Pharma, and Daiichi Sankyo announce second public recruitment offering of "Joinus", a joint research program to discover new drugs using drug-repositioning compound library

Sep 28,2018: New country manager brings significant business leadership and healthcare expertise to Mitsubishi Tanabe Pharma Canada

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Mitsubishi Tanabe Pharma Corp-Key Facts

Mitsubishi Tanabe Pharma Corp-Key Employees

Mitsubishi Tanabe Pharma Corp-Key Employee Biographies

Mitsubishi Tanabe Pharma Corp-Major Products and Services

Mitsubishi Tanabe Pharma Corp-History

Mitsubishi Tanabe Pharma Corp-Company Statement

Mitsubishi Tanabe Pharma Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Mitsubishi Tanabe Pharma Corp-Business Description

Product Category: Domestic Ethical Drugs

Performance

Product Category: OTC Products

Performance

Product Category: Others

Performance

Product Category: Overseas Ethical Drugs

Performance

Product Category: Royalty Revenue

Performance

Geographical Segment: Asia

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Japan

Performance

Geographical Segment: North America

Performance

Geographical Segment: Others

Performance

R&D Overview

Mitsubishi Tanabe Pharma Corp-SWOT Analysis

SWOT Analysis-Overview

Mitsubishi Tanabe Pharma Corp-Strengths

Mitsubishi Tanabe Pharma Corp-Weaknesses

Mitsubishi Tanabe Pharma Corp-Opportunities

Mitsubishi Tanabe Pharma Corp-Threats

Mitsubishi Tanabe Pharma Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Mitsubishi Tanabe Pharma Corp, Recent Deals Summary

Section 5-Company's Recent Developments

Apr 26, 2019: BioInvent receives EUR0.75 million milestone under Mitsubishi Tanabe Pharma partnership

Mar 20, 2019: Mitsubishi Tanabe Pharma: Aiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative officeAiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative office

Oct 09, 2018: Astellas, Mitsubishi Tanabe Pharma, and Daiichi Sankyo announce second public recruitment offering of "Joinus", a joint research program to discover new drugs using drug-repositioning compound library

Sep 28, 2018: New country manager brings significant business leadership and healthcare expertise to Mitsubishi Tanabe Pharma Canada

Sep 26, 2018: Mitsubishi Tanabe Pharma announce company name changes of our oversea subsidiaries

Sep 18, 2018: Mitsubishi Tanabe Pharma included in the Dow Jones Sustainability Asia Pacific Index

Jul 02, 2018: Mitsubishi Tanabe Pharma and Osaka University co-found the Department of Neuro-Medical Science-Toward the Innovative Drug Discovery for refractory Neurological Diseases

Jul 02, 2018: Mitsubishi Tanabe Pharma and Osaka University co-found the Department of Neuro-Medical Science

Jul 02, 2018: Mitsubishi Tanabe Pharma: Open Call for Applicants for investigator-Initiated Clinical Research Funds

May 30, 2018: Daiichi Sankyo Announces Launch of Immune-mediated Inflammatory Diseases Consortium for Drug Development

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Mitsubishi Tanabe Pharma Corp, Performance Chart (2015-2019)

Mitsubishi Tanabe Pharma Corp, Ratio Charts

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Mitsubishi Tanabe Pharma Corp, Key Facts

Mitsubishi Tanabe Pharma Corp, Key Employees

Mitsubishi Tanabe Pharma Corp, Key Employee Biographies

Mitsubishi Tanabe Pharma Corp, Major Products and Services

Mitsubishi Tanabe Pharma Corp, History

Mitsubishi Tanabe Pharma Corp, Other Locations

Mitsubishi Tanabe Pharma Corp, Subsidiaries

Mitsubishi Tanabe Pharma Corp, Joint Venture

Mitsubishi Tanabe Pharma Corp, Key Competitors

Mitsubishi Tanabe Pharma Corp, Ratios based on current share price

Mitsubishi Tanabe Pharma Corp, Annual Ratios

Mitsubishi Tanabe Pharma Corp, Annual Ratios (Cont...1)

Mitsubishi Tanabe Pharma Corp, Annual Ratios (Cont...2)

Mitsubishi Tanabe Pharma Corp, Interim Ratios

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Mitsubishi Tanabe Pharma Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Mitsubishi Tanabe Pharma Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Kissei Pharmaceutical Co Ltd

Astellas Pharma Inc

Tsumura & co

Taisho Pharmaceutical Holdings Co Ltd

Chugai Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd

Company Profile

Company Profile Title

Mitsubishi Tanabe Pharma Corp (4508)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, diabetes, kidney diseases, central nervous system (CNS) disorders and others. It also develops vaccines for preventing various infectious diseases. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe and North America. Mitsubishi Tanabe is headquartered in Chuo-ku, Osaka, Japan.

Mitsubishi Tanabe Pharma Corp Key Recent Developments

Apr 26,2019: BioInvent receives EUR0.75 million milestone under Mitsubishi Tanabe Pharma partnership

Mar 28,2019: The global health innovative technology fund provides grant for joint research into anti-malarial drugs conducted by Mitsubishi Tanabe Pharma and a malaria research institution

Mar 20,2019: Mitsubishi Tanabe Pharma: Aiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative officeAiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative office

Oct 09,2018: Astellas, Mitsubishi Tanabe Pharma, and Daiichi Sankyo announce second public recruitment offering of "Joinus", a joint research program to discover new drugs using drug-repositioning compound library

Sep 28,2018: New country manager brings significant business leadership and healthcare expertise to Mitsubishi Tanabe Pharma Canada

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Mitsubishi Tanabe Pharma Corp-Key Facts

Mitsubishi Tanabe Pharma Corp-Key Employees

Mitsubishi Tanabe Pharma Corp-Key Employee Biographies

Mitsubishi Tanabe Pharma Corp-Major Products and Services

Mitsubishi Tanabe Pharma Corp-History

Mitsubishi Tanabe Pharma Corp-Company Statement

Mitsubishi Tanabe Pharma Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2-Company Analysis

Company Overview

Mitsubishi Tanabe Pharma Corp-Business Description

Product Category: Domestic Ethical Drugs

Performance

Product Category: OTC Products

Performance

Product Category: Others

Performance

Product Category: Overseas Ethical Drugs

Performance

Product Category: Royalty Revenue

Performance

Geographical Segment: Asia

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Japan

Performance

Geographical Segment: North America

Performance

Geographical Segment: Others

Performance

R&D Overview

Mitsubishi Tanabe Pharma Corp-SWOT Analysis

SWOT Analysis-Overview

Mitsubishi Tanabe Pharma Corp-Strengths

Mitsubishi Tanabe Pharma Corp-Weaknesses

Mitsubishi Tanabe Pharma Corp-Opportunities

Mitsubishi Tanabe Pharma Corp-Threats

Mitsubishi Tanabe Pharma Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Mitsubishi Tanabe Pharma Corp, Recent Deals Summary

Section 5-Company's Recent Developments

Apr 26, 2019: BioInvent receives EUR0.75 million milestone under Mitsubishi Tanabe Pharma partnership

Mar 20, 2019: Mitsubishi Tanabe Pharma: Aiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative officeAiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative office

Oct 09, 2018: Astellas, Mitsubishi Tanabe Pharma, and Daiichi Sankyo announce second public recruitment offering of "Joinus", a joint research program to discover new drugs using drug-repositioning compound library

Sep 28, 2018: New country manager brings significant business leadership and healthcare expertise to Mitsubishi Tanabe Pharma Canada

Sep 26, 2018: Mitsubishi Tanabe Pharma announce company name changes of our oversea subsidiaries

Sep 18, 2018: Mitsubishi Tanabe Pharma included in the Dow Jones Sustainability Asia Pacific Index

Jul 02, 2018: Mitsubishi Tanabe Pharma and Osaka University co-found the Department of Neuro-Medical Science-Toward the Innovative Drug Discovery for refractory Neurological Diseases

Jul 02, 2018: Mitsubishi Tanabe Pharma and Osaka University co-found the Department of Neuro-Medical Science

Jul 02, 2018: Mitsubishi Tanabe Pharma: Open Call for Applicants for investigator-Initiated Clinical Research Funds

May 30, 2018: Daiichi Sankyo Announces Launch of Immune-mediated Inflammatory Diseases Consortium for Drug Development

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Mitsubishi Tanabe Pharma Corp, Performance Chart (2015-2019)

Mitsubishi Tanabe Pharma Corp, Ratio Charts

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Mitsubishi Tanabe Pharma Corp, Key Facts

Mitsubishi Tanabe Pharma Corp, Key Employees

Mitsubishi Tanabe Pharma Corp, Key Employee Biographies

Mitsubishi Tanabe Pharma Corp, Major Products and Services

Mitsubishi Tanabe Pharma Corp, History

Mitsubishi Tanabe Pharma Corp, Other Locations

Mitsubishi Tanabe Pharma Corp, Subsidiaries

Mitsubishi Tanabe Pharma Corp, Joint Venture

Mitsubishi Tanabe Pharma Corp, Key Competitors

Mitsubishi Tanabe Pharma Corp, Ratios based on current share price

Mitsubishi Tanabe Pharma Corp, Annual Ratios

Mitsubishi Tanabe Pharma Corp, Annual Ratios (Cont...1)

Mitsubishi Tanabe Pharma Corp, Annual Ratios (Cont...2)

Mitsubishi Tanabe Pharma Corp, Interim Ratios

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Mitsubishi Tanabe Pharma Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Mitsubishi Tanabe Pharma Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Kissei Pharmaceutical Co Ltd

Astellas Pharma Inc

Tsumura & co

Taisho Pharmaceutical Holdings Co Ltd

Chugai Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd